StemGen, Inc. announced earnings results for the full year ended June 30, 2020. For the full year, the company announced sales was USD 19,350 compared to USD 22,058 a year ago. Operating loss was USD 67,070 compared to USD 243,186 a year ago. Net loss was USD 230,772 compared to USD 425,510 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago.